
Investment Rating - The report maintains a "Buy" rating for the company [6] Core Views - In Q1 2025, the company achieved revenue of 2.2 billion yuan, a year-on-year increase of 35%, but a quarter-on-quarter decrease of 39%. The net profit attributable to the parent company was 300 million yuan, up 26% year-on-year but down 55% quarter-on-quarter. The non-recurring net profit was also 300 million yuan, reflecting a 13% year-on-year increase but a 48% quarter-on-quarter decrease [4][5] - For the year 2024, the company is projected to achieve revenue of 9.1 billion yuan, a year-on-year increase of 45%, with a net profit of 1.6 billion yuan, down 10% year-on-year, and a non-recurring net profit of 1.4 billion yuan, up 17% year-on-year [4][5] - The company invested 2.5 billion yuan in R&D in 2024, a 94% increase year-on-year, with an R&D expense ratio of 16%. The company is developing over 20 new devices, significantly accelerating the development timeline from 3-5 years to 2 years or less. This high R&D investment has led to increased product breakthroughs and new order growth [5] - The company's contract liabilities surged to 3.1 billion yuan in Q1, a year-on-year increase of 162%, indicating a strong order backlog [5] Financial Summary - The company’s projected financials for 2025-2027 include net profits of 2.48 billion, 3.41 billion, and 4.29 billion yuan respectively, with corresponding EPS of 3.96, 5.46, and 6.87 yuan. The price-to-earnings ratios (PE) are expected to be 45x, 33x, and 26x respectively [6] - Key financial metrics for 2024A to 2027E include: - Revenue growth rates of 44.7%, 33.7%, 28.9%, and 18.2% respectively - Net profit growth rates of -9.5%, 53.2%, 37.9%, and 25.8% respectively - Gross margin expected to improve from 41.1% in 2024 to 44.6% in 2027 [8]